Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management.

Gotlib J.

Am J Hematol. 2012 Sep;87(9):903-14. doi: 10.1002/ajh.23293.

PMID:
22926771
[PubMed - indexed for MEDLINE]
2.

World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management.

Gotlib J.

Am J Hematol. 2011 Aug;86(8):677-88. doi: 10.1002/ajh.22062. Review.

PMID:
21761433
[PubMed - indexed for MEDLINE]
3.

World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.

Gotlib J.

Am J Hematol. 2014 Mar;89(3):325-37. doi: 10.1002/ajh.23664. Review.

PMID:
24577808
[PubMed - indexed for MEDLINE]
4.

Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.

Tefferi A, Gotlib J, Pardanani A.

Mayo Clin Proc. 2010 Feb;85(2):158-64. doi: 10.4065/mcp.2009.0503. Epub 2010 Jan 6. Review.

PMID:
20053713
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Primary eosinophilic disorders: a concise review.

Pardanani A, Tefferi A.

Curr Hematol Malig Rep. 2008 Jan;3(1):37-43. doi: 10.1007/s11899-008-0007-9. Review.

PMID:
20425445
[PubMed - indexed for MEDLINE]
6.

Modern diagnosis and treatment of primary eosinophilia.

Tefferi A.

Acta Haematol. 2005;114(1):52-60. Review.

PMID:
15995325
[PubMed - indexed for MEDLINE]
7.

Eosinophilic myeloid disorders: new classification and novel therapeutic strategies.

Gotlib J.

Curr Opin Hematol. 2010 Mar;17(2):117-24. doi: 10.1097/MOH.0b013e3283366c70. Review.

PMID:
20071982
[PubMed - indexed for MEDLINE]
8.

The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases.

La Starza R, Specchia G, Cuneo A, Beacci D, Nozzoli C, Luciano L, Aventin A, Sambani C, Testoni N, Foppoli M, Invernizzi R, Marynen P, Martelli MF, Mecucci C.

Haematologica. 2005 May;90(5):596-601.

PMID:
15921374
[PubMed - indexed for MEDLINE]
Free Article
9.

Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy.

Gotlib J, Cross NC, Gilliland DG.

Best Pract Res Clin Haematol. 2006;19(3):535-69. Review.

PMID:
16781488
[PubMed - indexed for MEDLINE]
10.

Hypereosinophilic syndromes.

Roufosse FE, Goldman M, Cogan E.

Orphanet J Rare Dis. 2007 Sep 11;2:37. Review.

PMID:
17848188
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.

Valent P.

Blood Rev. 2009 Jul;23(4):157-65. doi: 10.1016/j.blre.2009.01.001. Epub 2009 Feb 25. Review.

PMID:
19246139
[PubMed - indexed for MEDLINE]
12.

Recent breakthroughs in the understanding and management of chronic eosinophilic leukemia.

Lierman E, Cools J.

Expert Rev Anticancer Ther. 2009 Sep;9(9):1295-304. doi: 10.1586/era.09.82. Review.

PMID:
19761433
[PubMed - indexed for MEDLINE]
13.

[Hematological disorders and hypereosinophilias].

Malfuson JV, Fagot T, Konopacki J, Mangouka L, Souleau B, de Revel T.

Rev Med Interne. 2009 Apr;30(4):322-30. doi: 10.1016/j.revmed.2008.10.019. Epub 2009 Feb 7. French.

PMID:
19201511
[PubMed - indexed for MEDLINE]
14.

Eosinophilic myeloid neoplasms.

Noel P, Mesa RA.

Curr Opin Hematol. 2013 Mar;20(2):157-62. doi: 10.1097/MOH.0b013e32835d81bf. Review.

PMID:
23385615
[PubMed - indexed for MEDLINE]
15.

Blood eosinophilia: a new paradigm in disease classification, diagnosis, and treatment.

Tefferi A.

Mayo Clin Proc. 2005 Jan;80(1):75-83. Review.

PMID:
15667033
[PubMed - indexed for MEDLINE]
16.

Eosinophilic myeloid disorders.

Noel P.

Semin Hematol. 2012 Apr;49(2):120-7. doi: 10.1053/j.seminhematol.2012.01.008. Review.

PMID:
22449622
[PubMed - indexed for MEDLINE]
17.

WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia.

Cilloni D, Messa F, Martinelli G, Gottardi E, Arruga F, Defilippi I, Carturan S, Messa E, Fava M, Giugliano E, Rosso V, Catalano R, Merante S, Nicoli P, Rondoni M, Ottaviani E, Soverini S, Tiribelli M, Pane F, Baccarani M, Saglio G.

Leukemia. 2007 Jul;21(7):1442-50. Epub 2007 May 17.

PMID:
17508006
[PubMed - indexed for MEDLINE]
18.
19.

A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophilia.

Kalac M, Quintás-Cardama A, Vrhovac R, Kantarjian H, Verstovsek S.

Cancer. 2007 Sep 1;110(5):955-64. Review.

PMID:
17654661
[PubMed - indexed for MEDLINE]
Free Article
20.

Imatinib therapy in clonal eosinophilic disorders, including systemic mastocytosis.

Tefferi A, Pardanani A.

Int J Hematol. 2004 Jun;79(5):441-7. Review.

PMID:
15239393
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk